Development Level

Tchem 144 | 1,890
Tbio 48 | 10,625
Tclin 40 | 602
Tdark 3 | 7,003

Collection

Kinase: IDG Consortium (Targets) 11 | 125
Kinase: IDG Consortium (Complete/Control) 2 | 37

IMPC Phenotype

preweaning lethality, complete... 16 | 633
preweaning lethality, incomple... 10 | 260
embryonic lethality prior to t... 6 | 187
abnormal embryo size 5 | 112
decreased bone mineral content 5 | 157
decreased lean body mass 5 | 195
embryonic lethality prior to o... 5 | 148
abnormal bone structure 4 | 131
decreased body weight 4 | 174
decreased total body fat amoun... 4 | 186
abnormal lens morphology 3 | 73
decreased body length 3 | 108
decreased circulating LDL chol... 3 | 37
decreased circulating choleste... 3 | 85
enlarged heart 3 | 111
increased circulating alkaline... 3 | 119
increased circulating choleste... 3 | 53
abnormal coat- hair morphology 2 | 18
abnormal eye morphology 2 | 38
abnormal gait 2 | 51
abnormal retina morphology 2 | 100
abnormal vibrissa morphology 2 | 17
anophthalmia 2 | 20
decreased blood urea nitrogen ... 2 | 31
decreased circulating iron lev... 2 | 25
decreased fasted circulating g... 2 | 49
enlarged spleen 2 | 26
hydrops fetalis 2 | 22
increased blood urea nitrogen ... 2 | 44
increased bone mineral density 2 | 52
increased circulating LDL chol... 2 | 15
increased circulating glucose ... 2 | 16
increased circulating iron lev... 2 | 25
increased circulating triglyce... 2 | 24
increased erythrocyte cell num... 2 | 26
increased or absent threshold ... 2 | 128
male infertility 2 | 62
microphthalmia 2 | 15
small superior vagus ganglion 2 | 20
small testis 2 | 37
tremors 2 | 34
abnormal cranium morphology 1 | 32
abnormal epididymis morphology 1 | 31
abnormal femur morphology 1 | 14
abnormal heart morphology 1 | 51
abnormal limb bud morphology 1 | 15
abnormal locomotor activation 1 | 26
abnormal neural tube closure 1 | 37
abnormal optic disc morphology 1 | 10
abnormal respiratory quotient 1 | 9
abnormal retinal blood vessel ... 1 | 18
abnormal retinal pigmentation 1 | 61
abnormal rib morphology 1 | 28
abnormal skin morphology 1 | 23
abnormal spleen morphology 1 | 36
abnormal startle reflex 1 | 14
abnormal testis morphology 1 | 30
absent vibrissae 1 | 14
cataract 1 | 26
craniofacial phenotype 1 | 9
cyanosis 1 | 6
decreased CD8-positive, alpha-... 1 | 26
decreased T cell number 1 | 31
decreased basophil cell number 1 | 11
decreased bone mineral density 1 | 126
decreased cervical vertebrae n... 1 | 12
decreased circulating creatini... 1 | 31
decreased circulating magnesiu... 1 | 11
decreased circulating serum al... 1 | 79
decreased circulating sodium l... 1 | 18
decreased circulating triglyce... 1 | 83
decreased eosinophil cell numb... 1 | 41
decreased grip strength 1 | 123
decreased hematocrit 1 | 25
decreased hemoglobin content 1 | 53
decreased lumbar vertebrae num... 1 | 62
decreased mean corpuscular hem... 1 | 34
decreased mean corpuscular hem... 1 | 19
decreased mean corpuscular vol... 1 | 50
edema 1 | 11
female infertility 1 | 34
hemorrhage 1 | 12
increased NK cell number 1 | 19
increased body weight 1 | 42
increased circulating HDL chol... 1 | 63
increased circulating alanine ... 1 | 11
increased circulating aspartat... 1 | 17
increased circulating bilirubi... 1 | 16
increased effector memory T-he... 1 | 5
increased eosinophil cell numb... 1 | 9
increased mean platelet volume 1 | 19
increased memory-marker gamma-... 1 | 2
increased red blood cell distr... 1 | 21
increased respiratory quotient 1 | 12
increased sacral vertebrae num... 1 | 62
limb grasping 1 | 35
respiratory system phenotype 1 | 2
short tibia 1 | 82
small adrenal glands 1 | 15
thrombocytosis 1 | 23

Disease

ovarian cancer 146 | 8,491
osteosarcoma 133 | 7,933
glioblastoma 111 | 5,572
Cancer 105 | 2,346
psoriasis 104 | 6,685
medulloblastoma, large-cell 102 | 6,234
lung cancer 86 | 4,473
atypical teratoid / rhabdoid tumor 76 | 4,369
pilocytic astrocytoma 66 | 3,086
malignant mesothelioma 63 | 3,163
intraductal papillary-mucinous neoplasm (IPMN) 58 | 3,289
oligodendroglioma 54 | 2,849
primitive neuroectodermal tumor 54 | 3,031
Breast cancer 53 | 3,098
pediatric high grade glioma 53 | 2,712
ependymoma 52 | 2,514
non-small cell lung cancer 52 | 2,798
lung carcinoma 51 | 2,844
Carcinoma 47 | 2,147
invasive ductal carcinoma 43 | 2,950
intraductal papillary-mucinous adenoma (IPMA) 42 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 42 | 2,988
subependymal giant cell astrocytoma 42 | 2,287
ulcerative colitis 41 | 2,087
lung adenocarcinoma 37 | 2,714
Multiple myeloma 35 | 1,327
adult high grade glioma 34 | 2,148
astrocytoma 34 | 1,493
interstitial cystitis 33 | 2,299
astrocytic glioma 32 | 2,241
diabetes mellitus 32 | 1,663
tuberculosis 32 | 1,563
Pick disease 31 | 1,893
group 3 medulloblastoma 31 | 2,254
Alzheimer's disease 30 | 644
group 4 medulloblastoma 30 | 1,875
pancreatic cancer 30 | 2,300
adrenocortical carcinoma 29 | 1,427
medulloblastoma 26 | 1,524
pituitary cancer 26 | 1,972
Rheumatoid Arthritis 25 | 1,170
colon cancer 25 | 1,475
pancreatic ductal adenocarcinoma liver metastasis 25 | 1,795
cystic fibrosis 24 | 1,670
Renal Cell Carcinoma 23 | 199
breast carcinoma 23 | 1,614
posterior fossa group A ependymoma 23 | 1,511
Mammary Neoplasms 22 | 410
sonic hedgehog group medulloblastoma 20 | 1,482
Obesity 19 | 616
Vascular disease 19 | 281
Waldenstrons macroglobulinemia 19 | 764
ductal carcinoma in situ 19 | 1,745
juvenile dermatomyositis 19 | 1,189
primary Sjogren syndrome 19 | 788
atypical teratoid/rhabdoid tumor 18 | 1,095
primary pancreatic ductal adenocarcinoma 18 | 1,271
Parkinson's disease 17 | 364
cutaneous lupus erythematosus 17 | 1,056
posterior fossa group B ependymoma 17 | 1,530
Prostatic Neoplasms 16 | 471
Schizophrenia 16 | 503
dermatomyositis 16 | 966
non-small cell lung carcinoma 16 | 413
spina bifida 16 | 1,064
Hamman-Rich syndrome 15 | 35
Lung Neoplasms 15 | 171
acute myeloid leukemia 15 | 785
active Crohn's disease 14 | 918
acute quadriplegic myopathy 14 | 1,157
non primary Sjogren syndrome sicca 14 | 840
Blastic phase chronic myeloid leukemia 13 | 58
Chronic Myelocytic Leukemia Accelerated Phase 13 | 59
Intellectual disability 13 | 573
Stomach Neoplasms 13 | 282
Toxic encephalopathy 13 | 131
esophageal adenocarcinoma 13 | 737
Atopic dermatitis 12 | 944
Gastrointestinal stromal tumor 12 | 61
Kidney disease 12 | 397
Melanoma 12 | 261
Arthritis 11 | 248
Asthma 11 | 349
Heart disease 11 | 279
Pancreatic Neuroendocrine Tumor 11 | 45
Peripheral Neuropathy 11 | 303
Philadelphia chromosome-positive acute lymphoblastic leukemia 11 | 47
Carcinoma of thyroid 10 | 17
Cardiomyopathies 10 | 90
Chronic phase chronic myeloid leukemia 10 | 45
HIV Infections 10 | 99
IGA Glomerulonephritis 10 | 454
Papillary thyroid carcinoma 10 | 37
Philadelphia Chromosome Positive Chronic Myelocytic Leukemia 10 | 45
Sarcoma of soft tissue 10 | 11
nasopharyngeal carcinoma 10 | 1,056
Crohn's disease 9 | 304
Hyperalgesia 9 | 71
Neurodegenerative disease 9 | 383
chronic lymphocytic leukemia 9 | 244

Tissue

Blood and immune system 235 | 17,994
Female tissues 235 | 18,646
Liver and Pancreas 235 | 18,135
Nervous System 235 | 18,560
Cardiovascular System 234 | 17,957
Digestive Tract 234 | 18,472
Endocrine System 234 | 18,511
Male tissues 234 | 17,968
Urinary Tract 234 | 18,443
Respiratory system 233 | 17,483
Skin and soft tissues 231 | 18,114

Target Family

Kinase 160 | 634
Enzyme 68 | 4,146
Non-IDG 7 | 11,969

PathwayCommons: inoh Pathway

Drosophila Toll-like receptor ... 235 | 235
Heterotrimeric GPCR signaling ... 235 | 235
Heterotrimeric GPCR signaling ... 233 | 233
Heterotrimeric GPCR signaling ... 224 | 224
Heterotrimeric GTP-binding pro... 224 | 224
Heterotrimeric GPCR signaling ... 223 | 223
Heterotrimeric GTP-binding pro... 223 | 223
VEGF signaling pathway ( VEGF ... 183 | 183
Positive regulation of (Transc... 178 | 178
AKT(PKB)-Bad signaling ( EPO s... 173 | 173
AKT(PKB)-Bad signaling ( IL-7 ... 173 | 173
Integrin signaling pathway ( I... 123 | 123
JAK-STAT pathway and regulatio... 96 | 96
Purine nucleotides and Nucleos... 85 | 85
B cell receptor signaling path... 60 | 60
Tryptophan degradation ( Trypt... 60 | 60
Insulin receptor signaling (Ma... 58 | 58
Canonical Wnt signaling pathwa... 56 | 56
Canonical Wnt signaling pathwa... 56 | 56
Canonical Wnt signaling pathwa... 56 | 56
Canonical Wnt signaling pathwa... 56 | 56
Canonical Wnt signaling pathwa... 56 | 56
Insulin receptor signaling ( I... 55 | 55
TGF-beta_super_family_signalin... 51 | 51
Mammalian Wnt signaling pathwa... 49 | 49
Signaling with Wnt (Canonical)... 47 | 47
Signaling with Wnt (Canonical)... 47 | 47
Signaling with Wnt (Canonical)... 47 | 47
Signaling with Wnt (Canonical)... 47 | 47
Signaling with Wnt (Canonical)... 47 | 47
Signaling with Wnt (Mammal) ( ... 47 | 47
TGF beta receptor complex degr... 47 | 47
Heterotrimeric GPCR signaling ... 45 | 45
FGF signaling pathway ( FGF si... 44 | 44
T cell receptor signaling path... 43 | 43
Inositol phosphate metabolism ... 42 | 42
TGF beta receptor I degradatio... 42 | 42
CD4 T cell receptor signaling ... 40 | 40
Cytokine receptor degradation ... 40 | 40
Negative regulation of (Phosph... 40 | 40
T cell receptor signaling (PLC... 40 | 40
SnoN degradation signaling ( T... 37 | 37
T cell receptor signaling (PLC... 37 | 37
G alpha i GDP-GTP exchange sig... 36 | 36
G alpha i GDP-GTP exchange sig... 36 | 36
G alpha s GDP-GTP exchange sig... 35 | 35
G alpha s GDP-GTP exchange sig... 35 | 35
G alpha s GDP-GTP exchange sig... 35 | 35
BMP signaling pathway ( TGF-be... 34 | 34
HGF signaling pathway ( HGF si... 30 | 30
Pyrimidine Nucleotides and Nuc... 30 | 30
Arginine and Proline metabolis... 29 | 29
PDGF signaling pathway (Mammal... 29 | 29
Xenopus axis formation Wnt sig... 28 | 28
Glycine and Serine metabolism ... 27 | 27
IGF1 signaling pathway ( IGF1 ... 27 | 27
Stabilization and accumulation... 24 | 24
Stabilization and accumulation... 24 | 24
Stabilization and accumulation... 24 | 24
Stabilization and accumulation... 24 | 24
Stabilization and accumulation... 24 | 24
Stabilization and accumulation... 24 | 24
Prostaglandin and Leukotriene ... 22 | 22
Fas signaling pathway ( Fas si... 21 | 21
Negative regulation of (G alph... 21 | 21
Negative regulation of (G alph... 21 | 21
Negative regulation of (transc... 21 | 21
FGF8 signaling pathway(Mouse) ... 20 | 20
Negative regulation of (G alph... 20 | 20
Negative regulation of (G alph... 20 | 20
Negative regulation of heterot... 20 | 20
Canonical Notch signaling path... 19 | 19
IFN alpha signaling pathway((J... 19 | 19
Signaling with Wnt (Xenopus) (... 19 | 19
Toll-like receptor signaling p... 19 | 19
Wnt secretory pathway (Canonic... 19 | 19
Wnt secretory pathway (Canonic... 19 | 19
Wnt secretory pathway (Canonic... 19 | 19
Wnt secretory pathway (Canonic... 19 | 19
Wnt secretory pathway (Canonic... 19 | 19
Wnt secretory pathway (Mammal)... 19 | 19
FGF8 signaling pathway(Xenopus... 18 | 18
Heterotrimeric GPCR signaling ... 18 | 18
Histidine degradation ( Histid... 18 | 18
IFN alpha signaling pathway(JA... 18 | 18
Nicotinate and Nicotinamide me... 18 | 18
PKA activation signaling ( GPC... 18 | 18
PKA activation signaling ( GPC... 18 | 18
Ci/Gli processing signaling ( ... 17 | 17
ERK cascade ( FGF8 signaling (... 17 | 17
ERK cascade ( FGF8 signaling (... 17 | 17
IFN alpha signaling pathway(JA... 17 | 17
IFN alpha signaling pathway(JA... 17 | 17
Folate metabolism ( Folate met... 16 | 16
JNK cascade ( IL-1 signaling p... 16 | 16
Methionine and Cysteine metabo... 16 | 16
NGF signaling pathway ( NGF si... 16 | 16
Valine,Leucine and Isoleucine ... 16 | 16
p38 cascade ( IL-1 signaling p... 16 | 16
IL-1_signaling(through_IKK-NFk... 15 | 15

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Receptor-interacting serine/threonine-protein kinase 3 RIPK3 Tchem Kinase -2.11581 129.5 456
High affinity nerve growth factor receptor NTRK1 Tchem Kinase -3.03552 1003.4 1000
Vascular endothelial growth factor receptor 1 FLT1 Tclin Kinase -3.36387 2061.0 806
Ribosomal protein S6 kinase alpha-6 RPS6KA6 Tchem Kinase -1.24881 21.2 139
Serine/threonine-protein kinase B-raf BRAF Tclin Kinase -2.28702 199.1 1276
Cyclin-dependent-like kinase 5 CDK5 Tchem Kinase -3.04076 1184.8 589
Cyclin-dependent kinase 6 CDK6 Tclin Kinase -2.67376 362.2 617
Cyclin-dependent kinase 3 CDK3 Tchem Kinase -1.41643 22.4 64
Mitogen-activated protein kinase 12 MAPK12 Tchem Kinase -1.91165 83.2 324
Mitogen-activated protein kinase 10 MAPK10 Tchem Kinase -2.27384 181.6 339